When Abbott Laboratories was hit with a huge jury verdict on a patent infringement suit, no one felt more pressure than general counsel Laura Schumacher. She had to recommend whether the company should settle — or roll the dice on an appeal.
Schumacher was convinced her company was in the right. But she’d felt the same way right up to the day in June 2009 when the jury awarded the plaintiff, Centocor Ortho Biotech Inc., $1.67 billion. “You can’t just be unabashed and say, ‘We’re gonna win.’ You have to consider everything,” says Schumacher.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
